CLOCORTOLONE PIVALATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clocortolone Pivalate, and what generic alternatives are available?
Clocortolone Pivalate is a drug marketed by Taro and is included in one NDA.
The generic ingredient in CLOCORTOLONE PIVALATE is clocortolone pivalate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clocortolone pivalate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clocortolone Pivalate
A generic version of CLOCORTOLONE PIVALATE was approved as clocortolone pivalate by TARO on April 21st, 2020.
Summary for CLOCORTOLONE PIVALATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 2 |
Patent Applications: | 4,238 |
Drug Prices: | Drug price information for CLOCORTOLONE PIVALATE |
What excipients (inactive ingredients) are in CLOCORTOLONE PIVALATE? | CLOCORTOLONE PIVALATE excipients list |
DailyMed Link: | CLOCORTOLONE PIVALATE at DailyMed |
Recent Clinical Trials for CLOCORTOLONE PIVALATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
WAYCro | Phase 1 |
Taro Pharmaceuticals USA | Phase 1 |
Promius Pharma, LLC | Phase 4 |
Pharmacology for CLOCORTOLONE PIVALATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for CLOCORTOLONE PIVALATE
US Patents and Regulatory Information for CLOCORTOLONE PIVALATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | CLOCORTOLONE PIVALATE | clocortolone pivalate | CREAM;TOPICAL | 206370-001 | Apr 21, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |